Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Deoxyribonuclease" patented technology

A deoxyribonuclease (DNase, for short) is an enzyme that catalyzes the hydrolytic cleavage of phosphodiester linkages in the DNA backbone, thus degrading DNA. Deoxyribonucleases are one type of nuclease, a generic term for enzymes capable of hydrolyzing phosphodiester bonds that link nucleotides. A wide variety of deoxyribonucleases are known, which differ in their substrate specificities, chemical mechanisms, and biological functions.

Normal temperature amplification-CRISPR Cas12a one-pot method nucleic acid detection system and application thereof

The invention relates to a normal temperature amplification-CRISPR Cas12a one-pot method detection system and a nucleic acid detection method based on the detection system. The detection system consists of a normal-temperature nucleic acid amplification system (unit I) which focuses on target signal amplification and a CRISPR Cas12a system (unit II) which focuses on target recognition and signal output. By means of a self-driven and deoxyribozyme-mediated reaction equilibrium transfer strategy, the equilibrium in the initial stage of the reaction tends to the unit I, and the equilibrium in the middle and later stages of the reaction tends to the unit II, so that the compatibility of the two units is remarkably improved. By means of the system, high-sensitivity and high-specificity portable one-pot detection of nucleic acid targets can be achieved.
Owner:HANGZHOU FOSTER BIOTECHNOLOGY CO LTD

Compositions and methods for adeno-associated (AAV) virus dnase expression

PCT designated stageWO2026111749A1VectorsPeptide/protein ingredientsRibonucleaseNeuro-degenerative disease
The invention relates to gene therapy, and more specifically, to AAV gene therapy vectors containing a novel chimeric deoxyribonuclease (DNase) protein transgene and methods of treating ailments such as cancer and neurodegeneration.
Owner:CLS THERAPEUTICS LLC

Targeting sieve tube-vector insect lysozyme-nano magnesium composite system and application thereof in prevention and control of areca yellows

The invention belongs to the technical field of agricultural biological protection, and discloses a targeted screen tube-vector insect lysozyme-nano magnesium compound system and application thereof in prevention and control of areca yellows, the compound system comprises an in-plant treatment module and a propagation blocking module, the in-plant treatment module comprises a screen tube targeted delivery unit, and the propagation blocking module comprises a propagation blocking unit. The sieve tube targeted delivery unit is formed by combining betel nut sieve tube navigation peptide ArePEP1 and a lysozyme-nano magnesium complex through a non-covalent bond; the propagation blocking module comprises an antifeedant micro-capsule activated by salivary enzyme of a vector insect, and phytoplasma deoxyribozyme PdeA and an insect antifeedant are encapsulated in the antifeedant micro-capsule; the target sequence of the phytoplasma deoxyribozyme PdeA is 5 '-GGAAACAG-3'; the in-plant treatment module and the propagation blocking module are jointly loaded on the same delivery vehicle. According to the areca yellows prevention and control compound system and the application method, pathogens in plants can be synchronously inhibited, insect propagation can be blocked, and high-altitude accurate delivery can be realized.
Owner:JIANGXI YUANSHENG CHUANGHE BIOTECHNOLOGY CO LTD

A specific recognition RNA-m 1 Chain-like deoxyribonuclease probes at A methylation sites and their applications

The application discloses a specific RNA-m 1 The application discloses a chain deoxyribozyme probe for specifically recognizing RNA-m 1 The application discloses a chain deoxyribozyme probe for specifically recognizing RNA-m 1 The application discloses a chain deoxyribozyme probe for specifically recognizing RNA-m
Owner:DALIAN UNIV OF TECH

Compositions and methods for adeno-associated (AAV) virus dnase expression

PCT designated stageWO2026111750A1Peptide/protein ingredientsHydrolasesRibonucleaseNeuro-degenerative disease
The invention relates to gene therapy, and more specifically, to AAV gene therapy vectors containing a novel chimeric deoxyribonuclease (DNase) protein transgene and methods of treating ailments such as cancer and neurodegeneration.
Owner:CLS THERAPEUTICS LLC